摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(E)-3-(6-nitrobenzo[d][1,3]dioxol-5-yl)-1-phenylprop-2-en-1-one | 34192-86-4

中文名称
——
中文别名
——
英文名称
(E)-3-(6-nitrobenzo[d][1,3]dioxol-5-yl)-1-phenylprop-2-en-1-one
英文别名
(E)-3-(6-nitro-1,3-benzodioxol-5-yl)-1-phenylprop-2-en-1-one
(E)-3-(6-nitrobenzo[d][1,3]dioxol-5-yl)-1-phenylprop-2-en-1-one化学式
CAS
34192-86-4
化学式
C16H11NO5
mdl
——
分子量
297.267
InChiKey
VRSXBGRXFBVWBT-VOTSOKGWSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    165-166 °C(Solv: chloroform (67-66-3); acetic acid (64-19-7))
  • 沸点:
    484.4±45.0 °C(Predicted)
  • 密度:
    1.396±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    22
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.06
  • 拓扑面积:
    81.4
  • 氢给体数:
    0
  • 氢受体数:
    5

SDS

SDS:49f6cfe008a0793eb817ad983516c1a5
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Pharmacologically active compounds, methods for the preparation thereof
    申请人:Orion-yhtyma Oy
    公开号:US04963590A1
    公开(公告)日:1990-10-16
    Pharmacologically active catechol derivatives of formula I ##STR1## wherein R.sub.1 and R.sub.2 independently comprise hydrogen, alkyl, acyl, optionally substituted aroyl, lower alkylsulfonyl or alkylcabamoyl or taken together form a lower alkylidene or cycloalkylidene, X comprises an electronegative substituent such as halogen, nitro, cyano, lower alkylsulfonyl, sulfonamido, aldehyde, caboxyl or trifluoromethyl and R.sub.3 comprises hydrogen, halogen, hydroxy alkyl, amino, nitro, cyano, trifluoromethyl, lower alkylsulfonyl, sulfonamide, aldehyde, alkyl carbonyl, aralkylidene carbonyl or carboxyl or a group selected from ##STR2## wherein R.sub.4 comprises hydrogen, alkyl, cyano, carboxyl or acyl and R.sub.5 comprises hydrogen, cyano, carboxyl, alkoxycarbonyl, carboxyalkenyl, nitro, acyl, optionally substituted aroyl or heteroaroyl, hydroxyalkyl or carboxyalkyl or R.sub.4 and R.sub.5 together form a five to seven membered substituted cycloalkanone ring; --(CO).sub.n (CH.sub.2).sub.m --COR wherein n is 0-1 and m is 0-7 and R comprises hydroxy, alkyl, carboxyalkyl, optionally substituted alkene, alkoxy or optionally substituted amino; ##STR3## wherein R.sub.8 and R.sub.9 independently comprise hydrogen or one of the following optionally substituted groups; alkyl, alkenyl, alkynyl, cycloalkyl, aralkyl, or together form an optionally substituted piperidyl group; --NH--CO--R.sub.10 wherein R.sub.10 comprises a substituted alkyl group.
    公式I的药理活性儿茶酚衍生物,其中R.sub.1和R.sub.2独立地包括氢、烷基、酰基、可选择地取代的芳酰基、较低的烷基磺酰基或烷基氨基甲酰基,或者一起形成较低的烷基亚甲基或环烷基亚甲基,X包括电负取代基,如卤素、硝基、氰基、较低的烷基磺酰基、磺胺基、醛基、羧基或三氟甲基,R.sub.3包括氢、卤素、羟基烷基、氨基、硝基、氰基、三
  • Continuous Flow Synthesis of Quinolines via a Scalable Tandem Photoisomerization‐Cyclization Process
    作者:Mara Di Filippo、Marcus Baumann
    DOI:10.1002/ejoc.202000957
    日期:2020.10.22
    A continuous flow process exploiting a light‐driven method for generating a series of drug‐like quinolines is reported and applied to the synthesis of the alkaloid natural product galipinine.
    据报道,利用光驱动方法的连续流动过程产生了一系列药物样喹啉,并将其应用于生物碱天然产物加利普宁的合成。
  • Enantioselective Synthesis of 2,2,3-Trisubstituted Indolines via Bimetallic Relay Catalysis of α-Diazoketones with Enones
    作者:Jian Yang、Chaoqi Ke、Dong Zhang、Xiaohua Liu、Xiaoming Feng
    DOI:10.1021/acs.orglett.8b01744
    日期:2018.8.3
    An efficient asymmetric intramolecular trapping of ammonium ylides of α-diazoketones with enones to synthesize indoline derivatives was realized. A Rh(II)/chiral N,N′-dioxide−Sc(III) complex bimetallic relay catalytic system was established. A series of optically active 2,2,3-trisubstituted indolines were obtained in high yields (up to 99%), good enantioselectivities (up to 99% ee), and excellent
    实现了一种高效的不对称分子内捕获α-重氮酮的酰化铵与烯酮合成二氢吲哚衍生物的方法。建立了Rh(II)/手性N,N'-二氧化物-Sc(III)复合双金属中继催化体系。在温和的反应条件下,以高收率(高达99%),良好的对映选择性(高达99%ee)和出色的非对映选择性(高达> 19:1 dr)获得了一系列旋光的2,2,3-三取代的二氢吲哚。条件。
  • 2-acyl indole derivatives and their use as antitumor agents
    申请人:Baxter Oncology GmbH
    公开号:US20030158216A1
    公开(公告)日:2003-08-21
    The invention relates to novel indole and heteroindole derivatives of the formula I 1 to their tautomers, their stereoisomers, their mixtures and their salts, to their preparation and to the use of indole derivatives of the formula I as antitumor agents.
    本发明涉及式 I 的新型吲哚和杂吲哚衍生物 1 的同分异构体、立体异构体、混合物及其盐类、它们的制备以及式 I 的吲哚衍生物作为抗肿瘤药的用途。
  • N<sub>2</sub>H<sub>4</sub>–H<sub>2</sub>O Enabled Umpolung Cyclization of <i>o</i>-Nitro Chalcones for the Construction of Quinoline <i>N</i>-Oxides
    作者:Guan Zhang、Kai Yang、Shihui Wang、Qiang Feng、Qiuling Song
    DOI:10.1021/acs.orglett.0c04162
    日期:2021.1.15
查看更多